CARMIL2 deficiency causes defective CD28-mediated T cell co-stimulation, altered cytoskeletal dynamics, susceptibility to various infections and an Epstein–Barr virus-induced smooth muscle tumor (EBV-SMT) [32]. Here, CARMIL2 is linked to smooth muscle tumor.